|
|
negative regulation of axon extension
|
GO:0030517 |
2 |
0.914
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.882
|
|
|
|
primary alcohol metabolic process
|
GO:0034308 |
17 |
0.881
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.873
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.863
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.842
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.807
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.769
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.742
|
|
|
|
negative regulation of cardiac muscle cell proliferation
|
GO:0060044 |
2 |
0.716
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.695
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.689
|
|
|
|
neutral lipid catabolic process
|
GO:0046461 |
12 |
0.673
|
|
|
|
cellular response to superoxide
|
GO:0071451 |
6 |
0.652
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.627
|
|
|
|
cellular response to reactive oxygen species
|
GO:0034614 |
50 |
0.619
|
|
|
|
lipid transport
|
GO:0006869 |
90 |
0.608
|
|
|
|
response to nitric oxide
|
GO:0071731 |
4 |
0.590
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
4 |
0.581
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.581
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.578
|
|
|
|
cellular response to oxygen radical
|
GO:0071450 |
6 |
0.560
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.558
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.557
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
63 |
0.554
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
114 |
0.553
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.535
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.524
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.521
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.521
|
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.514
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.509
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.503
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
20 |
0.492
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.473
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.469
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
27 |
0.468
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.465
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.460
|
|
|
|
regulation of triglyceride catabolic process
|
GO:0010896 |
6 |
0.456
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.454
|
|
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.450
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.446
|
|
|
|
digestive system process
|
GO:0022600 |
17 |
0.445
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.432
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.422
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.414
|
|
|
|
negative regulation of axonogenesis
|
GO:0050771 |
4 |
0.409
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.407
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
15 |
0.405
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.404
|
|
|
|
regulation of heart growth
|
GO:0060420 |
4 |
0.403
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.403
|
|
|
|
cellular hormone metabolic process
|
GO:0034754 |
41 |
0.397
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.390
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
107 |
0.390
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.378
|
|
|
|
vitamin transport
|
GO:0051180 |
14 |
0.378
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.376
|
|
|
|
embryonic retina morphogenesis in camera type eye
|
GO:0060059 |
1 |
0.372
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.370
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.369
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.367
|
|
|
|
sterol transport
|
GO:0015918 |
39 |
0.367
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.367
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.366
|
|
|
|
growth
|
GO:0040007 |
202 |
0.361
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
18 |
0.357
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.350
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.349
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.348
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.348
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.348
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.346
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.344
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.341
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
75 |
0.340
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
65 |
0.336
|
|
|
|
very low density lipoprotein particle remodeling
|
GO:0034372 |
10 |
0.328
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.322
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.315
|
|
|
|
glucose homeostasis
|
GO:0042593 |
31 |
0.311
|
|
|
|
retinol metabolic process
|
GO:0042572 |
7 |
0.309
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
26 |
0.308
|
|
|
|
negative regulation of developmental growth
|
GO:0048640 |
10 |
0.305
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
35 |
0.300
|
|
|
|
macromolecular complex remodeling
|
GO:0034367 |
16 |
0.295
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.289
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.276
|
|
|
|
hexose metabolic process
|
GO:0019318 |
55 |
0.275
|
|
|
|
anion transport
|
GO:0006820 |
161 |
0.275
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.270
|
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.265
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.263
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.260
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
61 |
0.255
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.254
|
|
|
|
negative regulation of cardiac muscle tissue development
|
GO:0055026 |
7 |
0.254
|
|
|
|
negative regulation of heart growth
|
GO:0061117 |
2 |
0.253
|
|
|
|
negative regulation of striated muscle tissue development
|
GO:0045843 |
11 |
0.253
|
|
|
|
removal of superoxide radicals
|
GO:0019430 |
6 |
0.242
|
|
|
|
negative regulation of cardiac muscle tissue growth
|
GO:0055022 |
2 |
0.242
|
|
|
|
protein lipid complex remodeling
|
GO:0034368 |
16 |
0.240
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.238
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.238
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.236
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.235
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to oxidative stress
|
GO:0043619 |
5 |
0.233
|
|
|
|
female genitalia development
|
GO:0030540 |
2 |
0.229
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.219
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.209
|
|
|
|
tissue homeostasis
|
GO:0001894 |
63 |
0.209
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.208
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.207
|
|
|
|
sterol esterification
|
GO:0034434 |
10 |
0.203
|
|
|
|
activation of protein kinase activity
|
GO:0032147 |
90 |
0.203
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.198
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.198
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.196
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.195
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.194
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.189
|
|
|
|
negative regulation of multicellular organismal metabolic process
|
GO:0044252 |
3 |
0.189
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.185
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.183
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.183
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
2 |
0.182
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.181
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
27 |
0.181
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.180
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
67 |
0.178
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.178
|
|
|
|
phospholipid efflux
|
GO:0033700 |
11 |
0.177
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.177
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
87 |
0.174
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.172
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.172
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
31 |
0.170
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.167
|
|
|
|
system process
|
GO:0003008 |
349 |
0.166
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.166
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.164
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.164
|
|
|
|
regulation of oxidoreductase activity
|
GO:0051341 |
43 |
0.163
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.161
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.161
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.161
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
108 |
0.159
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.157
|
|
|
|
cellular response to hydrogen peroxide
|
GO:0070301 |
37 |
0.157
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
46 |
0.155
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.154
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.154
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.154
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.154
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.153
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
11 |
0.152
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.152
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
25 |
0.150
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.150
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.148
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.147
|
|
|
|
response to genistein
|
GO:0033595 |
1 |
0.145
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.144
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.143
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.143
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.141
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.141
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.140
|
|
|
|
organophosphate ester transport
|
GO:0015748 |
32 |
0.140
|
|
|
|
cellular aldehyde metabolic process
|
GO:0006081 |
20 |
0.140
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.139
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
11 |
0.138
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
4 |
0.135
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.135
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.134
|
|
|
|
nuclear import
|
GO:0051170 |
106 |
0.134
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.132
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.132
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
69 |
0.132
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
57 |
0.131
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.131
|
|
|
|
plasma lipoprotein particle organization
|
GO:0071827 |
22 |
0.131
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.131
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.130
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
23 |
0.129
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.128
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.128
|
|
|
|
response to peptide hormone
|
GO:0043434 |
61 |
0.128
|
|
|
|
detection of stimulus
|
GO:0051606 |
85 |
0.128
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.127
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.126
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.124
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.123
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.123
|
|
|
|
response to superoxide
|
GO:0000303 |
6 |
0.123
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
48 |
0.123
|
|
|
|
positive regulation of fibroblast migration
|
GO:0010763 |
3 |
0.123
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
4 |
0.122
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.121
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.119
|
|
|
|
actin filament based movement
|
GO:0030048 |
17 |
0.117
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.117
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.115
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
79 |
0.115
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.114
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.113
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
10 |
0.112
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.112
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.112
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.112
|
|
|
|
cellular response to drug
|
GO:0035690 |
27 |
0.111
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
42 |
0.110
|
|
|
|
protein secretion
|
GO:0009306 |
98 |
0.109
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
48 |
0.108
|
|
|
|
negative regulation of complement activation lectin pathway
|
GO:0001869 |
2 |
0.107
|
|
|
|
organic anion transport
|
GO:0015711 |
103 |
0.107
|
|
|
|
regulation of immune effector process
|
GO:0002697 |
91 |
0.104
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
60 |
0.104
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.104
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
45 |
0.103
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.102
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.102
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
21 |
0.102
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.101
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.100
|
|
|
|
negative regulation of muscle organ development
|
GO:0048635 |
12 |
0.099
|
|
|
|
digestion
|
GO:0007586 |
22 |
0.099
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.098
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
67 |
0.097
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.097
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.096
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
28 |
0.095
|
|
|
|
positive regulation of immunoglobulin production
|
GO:0002639 |
4 |
0.095
|
|
|
|
amide transport
|
GO:0042886 |
76 |
0.094
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
50 |
0.094
|
|
|
|
response to acid chemical
|
GO:0001101 |
66 |
0.093
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.093
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.090
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
1 |
0.088
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.088
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.088
|
|
|
|
regulation of complement activation lectin pathway
|
GO:0001868 |
2 |
0.087
|
|
|
|
triglyceride rich lipoprotein particle remodeling
|
GO:0034370 |
10 |
0.087
|
|
|
|
sterol homeostasis
|
GO:0055092 |
28 |
0.087
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.086
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.086
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.085
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.085
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
8 |
0.085
|
|
|
|
positive regulation of rho protein signal transduction
|
GO:0035025 |
4 |
0.084
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.083
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
76 |
0.083
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.083
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.083
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.082
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.082
|
|
|
|
superoxide metabolic process
|
GO:0006801 |
20 |
0.082
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
99 |
0.081
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.081
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.080
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
23 |
0.079
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.079
|
|
|
|
detection of stimulus involved in sensory perception
|
GO:0050906 |
43 |
0.078
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
56 |
0.077
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
13 |
0.076
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
32 |
0.076
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.076
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.076
|
|
|
|
negative regulation of neurogenesis
|
GO:0050768 |
26 |
0.076
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.076
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.075
|
|
|
|
negative regulation of amyloid precursor protein catabolic process
|
GO:1902992 |
4 |
0.075
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.075
|
|
|
|
negative regulation of muscle tissue development
|
GO:1901862 |
11 |
0.075
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.075
|
|
|
|
cell adhesion molecule production
|
GO:0060352 |
3 |
0.074
|
|
|
|
high density lipoprotein particle remodeling
|
GO:0034375 |
8 |
0.074
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.073
|
|
|
|
lung development
|
GO:0030324 |
20 |
0.073
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.073
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.073
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.072
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
43 |
0.072
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.072
|
|
|
|
positive regulation of lipoprotein lipase activity
|
GO:0051006 |
7 |
0.072
|
|
|
|
response to insulin
|
GO:0032868 |
45 |
0.071
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
104 |
0.071
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.071
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
25 |
0.070
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
19 |
0.070
|
|
|
|
renal water homeostasis
|
GO:0003091 |
4 |
0.070
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.069
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
8 |
0.069
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
57 |
0.069
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.068
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
62 |
0.067
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.067
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.067
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.067
|
|
|
|
glucose metabolic process
|
GO:0006006 |
45 |
0.067
|
|
|
|
regulation of immunoglobulin production
|
GO:0002637 |
4 |
0.067
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.066
|
|
|
|
phospholipid catabolic process
|
GO:0009395 |
12 |
0.066
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.065
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.065
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.065
|
|
|
|
jnk cascade
|
GO:0007254 |
80 |
0.065
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
24 |
0.065
|
|
|
|
respiratory tube development
|
GO:0030323 |
20 |
0.064
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.064
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.063
|
|
|
|
response to oxygen radical
|
GO:0000305 |
6 |
0.063
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.063
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.063
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
65 |
0.063
|
|
|
|
reverse cholesterol transport
|
GO:0043691 |
8 |
0.063
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.063
|
|
|
|
protein stabilization
|
GO:0050821 |
64 |
0.062
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.062
|
|
|
|
multicellular organismal lipid catabolic process
|
GO:0044240 |
2 |
0.062
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.062
|
|
|
|
regulation of vascular endothelial growth factor receptor signaling pathway
|
GO:0030947 |
9 |
0.062
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.061
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
16 |
0.061
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.061
|
|
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
11 |
0.061
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.060
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
34 |
0.060
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.060
|
|
|
|
response to activity
|
GO:0014823 |
0 |
0.060
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
61 |
0.060
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.059
|
|
|
|
regulation of necrotic cell death
|
GO:0010939 |
9 |
0.059
|
|
|
|
regulation of axonogenesis
|
GO:0050770 |
16 |
0.058
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.058
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.058
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.058
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.058
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.058
|
|
|
|
organic acid transport
|
GO:0015849 |
65 |
0.058
|
|
|
|
negative regulation of epithelial cell migration
|
GO:0010633 |
38 |
0.057
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
31 |
0.057
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.057
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.057
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.056
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.055
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.055
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.055
|
|
|
|
detection of light stimulus involved in visual perception
|
GO:0050908 |
9 |
0.054
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.053
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.053
|
|
|
|
smooth muscle cell migration
|
GO:0014909 |
18 |
0.053
|
|
|
|
response to hyperoxia
|
GO:0055093 |
4 |
0.052
|
|
|
|
epithelial structure maintenance
|
GO:0010669 |
9 |
0.052
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
4 |
0.052
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.052
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.051
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.051
|
|
|
|
inflammatory response
|
GO:0006954 |
79 |
0.051
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
42 |
0.051
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
82 |
0.051
|
|
|
|
necrotic cell death
|
GO:0070265 |
21 |
0.050
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.050
|
|
|
|
carbohydrate transport
|
GO:0008643 |
37 |
0.050
|
|
|
|
peptide secretion
|
GO:0002790 |
51 |
0.049
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.049
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.049
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.049
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.049
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
15 |
0.049
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.049
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.048
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
6 |
0.048
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.048
|
|
|
|
detection of external stimulus
|
GO:0009581 |
15 |
0.048
|
|
|
|
regulation of receptor catabolic process
|
GO:2000644 |
2 |
0.048
|
|
|
|
regulation of interleukin 1 beta secretion
|
GO:0050706 |
12 |
0.047
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.047
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.047
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
49 |
0.047
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.047
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.046
|
|
|
|
positive regulation of phagocytosis engulfment
|
GO:0060100 |
1 |
0.046
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
41 |
0.046
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.046
|
|
|
|
hormone transport
|
GO:0009914 |
68 |
0.046
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.046
|
|
|
|
response to cadmium ion
|
GO:0046686 |
10 |
0.046
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
69 |
0.045
|
|
|
|
developmental growth
|
GO:0048589 |
48 |
0.044
|
|
|
|
ethanolamine containing compound metabolic process
|
GO:0042439 |
26 |
0.044
|
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
83 |
0.044
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
17 |
0.043
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.043
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.042
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.042
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.042
|
|
|
|
cholesterol import
|
GO:0070508 |
4 |
0.042
|
|
|
|
postsynaptic membrane organization
|
GO:0001941 |
2 |
0.042
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.041
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
27 |
0.041
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.041
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.041
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.041
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
37 |
0.041
|
|
|
|
regulation of macrophage chemotaxis
|
GO:0010758 |
4 |
0.040
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
74 |
0.040
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.040
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
73 |
0.040
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.039
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
57 |
0.039
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
8 |
0.039
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.039
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
16 |
0.039
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
84 |
0.039
|
|
|
|
regulation of stress activated protein kinase signaling cascade
|
GO:0070302 |
85 |
0.039
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
23 |
0.039
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
15 |
0.039
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.038
|
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
27 |
0.038
|
|
|
|
neurotransmitter gated ion channel clustering
|
GO:0072578 |
1 |
0.038
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.038
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.038
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.038
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.038
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.037
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.037
|
|
|
|
neuron projection extension
|
GO:1990138 |
14 |
0.037
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.037
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.037
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.037
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.037
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
67 |
0.037
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.037
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.037
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
80 |
0.036
|
|
|
|
positive regulation of vascular endothelial growth factor receptor signaling pathway
|
GO:0030949 |
6 |
0.036
|
|
|
|
positive regulation of triglyceride lipase activity
|
GO:0061365 |
7 |
0.036
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.036
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.036
|
|
|
|
cholesterol transport
|
GO:0030301 |
39 |
0.036
|
|
|
|
immunoglobulin secretion
|
GO:0048305 |
1 |
0.036
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.036
|
|
|
|
regulation of smooth muscle cell migration
|
GO:0014910 |
15 |
0.036
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.035
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.035
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
93 |
0.035
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.035
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
7 |
0.035
|
|
|
|
regulation of lipoprotein oxidation
|
GO:0034442 |
3 |
0.035
|
|
|
|
regulation of myelination
|
GO:0031641 |
1 |
0.035
|
|
|
|
retinal metabolic process
|
GO:0042574 |
8 |
0.035
|
|
|
|
detection of visible light
|
GO:0009584 |
11 |
0.035
|
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
18 |
0.034
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
9 |
0.034
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
21 |
0.034
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.034
|
|
|
|
trabecula formation
|
GO:0060343 |
1 |
0.034
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
4 |
0.033
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.033
|
|
|
|
organ growth
|
GO:0035265 |
12 |
0.033
|
|
|
|
visual perception
|
GO:0007601 |
27 |
0.033
|
|
|
|
retina homeostasis
|
GO:0001895 |
42 |
0.033
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.032
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.032
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
6 |
0.032
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
4 |
0.032
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.032
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.031
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.031
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.031
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.031
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.031
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.031
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
24 |
0.031
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.031
|
|
|
|
plasminogen activation
|
GO:0031639 |
11 |
0.031
|
|
|
|
positive regulation of cgmp biosynthetic process
|
GO:0030828 |
3 |
0.031
|
|
|
|
protein import into nucleus translocation
|
GO:0000060 |
22 |
0.031
|
|
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.031
|
|
|
|
regulation of immunoglobulin secretion
|
GO:0051023 |
1 |
0.031
|
|
|
|
respiratory system development
|
GO:0060541 |
22 |
0.030
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.030
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
60 |
0.030
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.030
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.030
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
40 |
0.030
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.030
|
|